Transgender hormone therapy is quizlet

Submitted by anxiousahsoka.

Federal government websites often end in. The site is secure. Preview improvements coming to the PMC website in October Learn More or Try it out now. Recently, gender-affirming hormone therapy for gender incongruence has become an issue in various countries and organizations with various guidelines.

Transgender hormone therapy is quizlet

.

The rule was adopted in to carry out a major civil rights law embedded in the Affordable Care Act. Spironolactone should be used as an androgen blocker in individuals with a high risk of hepatotoxicity. References 1.

.

Gender-affirming hormone therapy helps transgender and other gender-nonconforming people align their bodies with their gender identity. Not all transgender trans people are interested in hormone therapy. However, many transgender people, particularly binary transgender people, turn to hormones to affirm their gender. Gender-affirming hormone therapy is comprised of masculizing hormone therapy used in trans men and feminizing hormone therapy used in trans women. This article describes the goals of gender-affirming hormone therapy, how the treatment is administered, and the different types of hormones used. It also explains what to expect when undergoing gender-affirming hormone therapy and the possible risks. The term "gender affirmation" is preferred over "gender confirmation" because a transgender person does not need to confirm their gender to anyone.

Transgender hormone therapy is quizlet

Transgender hormone therapy , also called hormone replacement therapy HRT or gender-affirming hormone therapy GAHT , is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity. This form of hormone therapy is given as one of two types, based on whether the goal of treatment is masculinization or feminization :. Eligibility for transgender hormone therapy may be concluded by assessing a patient for gender dysphoria or persistent gender incongruence, though many medical institutions now used an informed consent model. This model ensures patients are informed of the procedure process, including possible benefits and risks, while removing many of the historical barriers needed to start hormone therapy. Treatment guidelines for therapy have been developed by several medical associations. Some intersex people may also undergo hormone therapy, either starting in childhood to confirm the sex they were assigned at birth , or later in order to align their sex with their gender identity. Non-binary people may also engage in hormone therapy in order to achieve a desired balance of sex hormones or to help align their bodies with their gender identities.

Charging cable for a samsung tablet

There is a lack of evidence that increased doses of testosterone have a more masculine effect after reaching maximal virilization in the first two years of treatment [ 7 , 24 ]. The Fenway guide to lesbian, gay, bisexual, and transgender health. It also has a weak estrogenic effect [ 36 ]. Spermatogenesis abnormalities following hormonal therapy in transwomen. Corresponding author. Most changes including fat redistribution and increased muscle mass are reversible, while deepening voice and male pattern hair loss are irreversible. Acne of the face, chest, and back, usually accompanied by hair growth, can commonly develop, or worsen in the first year of testosterone use. Progestogen Some providers argue that the use of progestogen i. Female-to-male masculinizing individuals 1. Cyproterone acetate is commonly used in Europe and South Korea not approved in the United States due to concerns of hepatotoxicity as an androgen blocker. Regimens are usually driven by standards of hormonal replacement therapy in hypogonadism i.

.

Thus, almost all international guidelines for transgender hormone treatment did not recommend their routine use [ 4 , 5 , 6 , 7 ]. Progestogen Amenorrhea is usually expected within a few months 3—6 months after initiation of testosterone treatment [ 8 , 9 ]. Gonadotropin-releasing hormone GnRH agonists might be alternatively considered for achieving amenorrhea. Cyproterone acetate d. The objective of this article is to describe current trends in clinical treatment for transgender and present available options of hormone therapy in South Korea. Boston: The Fenway Institute; Routine bone mineral density screening after age 65 if a patient is at low risk for osteoporosis. However, there is a lack of evidence for this cessation. J Menopausal Med. Effects of estrogen on spermatogenesis in transgender women. Endocrine treatment of transsexual persons: extensive personal experience. Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review.